A detailed history of Financial Management Network Inc transactions in Amgen Inc stock. As of the latest transaction made, Financial Management Network Inc holds 2,260 shares of AMGN stock, worth $640,958. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,260
Previous 2,258 0.09%
Holding current value
$640,958
Previous $705,000 3.26%
% of portfolio
0.17%
Previous 0.19%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$309.38 - $337.38 $618 - $674
2 Added 0.09%
2,260 $728,000
Q2 2024

Jul 22, 2024

BUY
$262.75 - $319.31 $11,561 - $14,049
44 Added 1.99%
2,258 $705,000
Q1 2024

Apr 22, 2024

BUY
$268.87 - $324.56 $268 - $324
1 Added 0.05%
2,214 $629,000
Q4 2023

Jan 22, 2024

BUY
$255.7 - $288.46 $511 - $576
2 Added 0.09%
2,213 $637,000
Q3 2023

Oct 23, 2023

BUY
$218.65 - $271.46 $437 - $542
2 Added 0.09%
2,211 $594,000
Q2 2023

Jul 28, 2023

SELL
$214.27 - $253.37 $5,999 - $7,094
-28 Reduced 1.25%
2,209 $490,000
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $4,809 - $6,111
21 Added 0.95%
2,237 $587,000
Q3 2022

Nov 03, 2022

SELL
$224.46 - $253.15 $11,223 - $12,657
-50 Reduced 2.21%
2,216 $516,000
Q2 2022

Jul 11, 2022

BUY
$230.71 - $256.74 $461 - $513
2 Added 0.09%
2,266 $556,000
Q1 2022

Apr 21, 2022

BUY
$219.27 - $242.57 $438 - $485
2 Added 0.09%
2,264 $554,000
Q4 2021

Jan 19, 2022

SELL
$198.88 - $227.6 $12,529 - $14,338
-63 Reduced 2.71%
2,262 $515,000
Q3 2021

Oct 13, 2021

SELL
$212.27 - $248.7 $68,563 - $80,330
-323 Reduced 12.2%
2,325 $492,000
Q2 2021

Jul 20, 2021

BUY
$233.58 - $259.14 $467 - $518
2 Added 0.08%
2,648 $659,000
Q1 2021

May 06, 2021

SELL
$221.91 - $258.6 $34,174 - $39,824
-154 Reduced 5.5%
2,646 $649,000
Q4 2020

Feb 08, 2021

BUY
$216.38 - $257.67 $605,864 - $721,476
2,800 New
2,800 $707,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Financial Management Network Inc Portfolio

Follow Financial Management Network Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Network Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Network Inc with notifications on news.